IGF/IGFR signaling pathway contributes to tumorigenesis and also drug resistance in thyroid cancer via activation of PI3K/AKT signaling pathway, leading to the expression of pro‐survival genes and increased cell proliferation. The gene discussed is IGF1; the disease is thyroid gland carcinoma.